ÂÜÀòÂÒÂ×

Karen Campbell has worked in the clinical development field since 2007. Karen began their career at Outcome as a Clinical Research Associate I, later becoming a Site Management Project Lead and Site Management Associate. In 2010, they moved to Dana-Farber Cancer Institute as a Clinical Research Manager. From 2012 to 2017, they worked at Merrimack as a Senior Clinical Trial Manager and Clinical Trial Manager. Karen then joined Jounce Therapeutics, Inc. as a Clinical Scientist and Senior Clinical Trial Lead. Since 2018, they have been employed at Rubius Therapeutics as a Senior Director Clinical Operations and Director, Clinical Development. Most recently, they were appointed Vice President Clinical Development Operations at Be Biopharma in 2023.

Karen Campbell attended the University of New Hampshire.